$PRFX Catalysts in the pipe. Lots of news.

I’ve been watching PRFX for a bit and wanted to share why it’s on my radar. On the pharma side, they’re working on a drop-less eye treatment for cataract surgery, which is one of the most common procedures out there, and they’re moving toward a Phase II trial. The idea is simple: instead of patients dealing with weeks of eye drops (which a lot of people mess up), the treatment is placed during surgery and releases medication over time. $PRFX also has DeepSolar, a software business focused on solar asset analytics and technical due diligence, which has been getting traction internationally. It’s an unusual mix, but it gives them more than one path forward instead of everything riding on a single binary event. I just like that there’s real development happening, a clear medical use case, and a chart that’s been behaving instead of going crazy. Curious if anyone else here is watching PRFX or has thoughts on it?